| Pharmacokinetic, behavioral, and brain activity effects of Δ9-tetrahydrocannabinol in adolescent male and female rats CM Ruiz, A Torrens, E Castillo, CR Perrone, J Cevallos, VC Inshishian, ... Neuropsychopharmacology 46 (5), 959-969, 2021 | 61 | 2021 |
| Comparative pharmacokinetics of Δ9-tetrahydrocannabinol in adolescent and adult male mice A Torrens, V Vozella, H Huff, B McNeil, F Ahmed, A Ghidini, SV Mahler, ... Journal of Pharmacology and Experimental Therapeutics 374 (1), 151-160, 2020 | 60 | 2020 |
| Pharmacokinetic and pharmacodynamic properties of aerosolized (“vaped”) THC in adolescent male and female rats CM Ruiz, A Torrens, V Lallai, E Castillo, L Manca, MX Martinez, ... Psychopharmacology 238, 3595-3605, 2021 | 29 | 2021 |
| Frequent low-dose Δ9-tetrahydrocannabinol in adolescence disrupts microglia homeostasis and disables responses to microbial infection and social stress in young adulthood HL Lee, KM Jung, Y Fotio, E Squire, F Palese, L Lin, A Torrens, F Ahmed, ... Biological psychiatry 92 (11), 845-860, 2022 | 19 | 2022 |
| Comparative Pharmacokinetics of Δ9-Tetrahydrocannabinol in Adolescent and Adult Male and Female Rats A Torrens, P Roy, L Lin, C Vu, D Grimes, VC Inshishian, JS Montesinos, ... Cannabis and cannabinoid research 7 (6), 814-826, 2022 | 14 | 2022 |
| Adolescent exposure to low-dose THC disrupts energy balance and adipose organ homeostasis in adulthood L Lin, KM Jung, HL Lee, J Le, G Colleluori, C Wood, F Palese, E Squire, ... Cell Metabolism 35 (7), 1227-1241. e7, 2023 | 7 | 2023 |
| A sensitive ultrahigh-performance liquid chromatography/tandem mass spectrometry method for the simultaneous analysis of phytocannabinoids and endocannabinoids in plasma and brain F Ahmed, A Torrens, SV Mahler, F Ferlenghi, MA Huestis, D Piomelli Cannabis and Cannabinoid Research 9 (1), 371-385, 2024 | 6 | 2024 |
| Nasal accumulation and metabolism of Δ9-tetrahydrocannabinol following aerosol (‘vaping’) administration in an adolescent rat model A Torrens, CM Ruiz, MX Martinez, AM Tagne, P Roy, D Grimes, F Ahmed, ... Pharmacological research 187, 106600, 2023 | 6 | 2023 |
| Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism F Palese, S Pontis, N Realini, A Torrens, F Ahmed, F Assogna, ... Pharmacological research 182, 106338, 2022 | 6 | 2022 |
| Diet-induced obesity disrupts histamine-dependent oleoylethanolamide signaling in the mouse liver L Lin, A Mabou Tagne, EN Squire, HL Lee, Y Fotio, J Ramirez, M Zheng, ... Pharmacology 107 (7-8), 423-432, 2022 | 6 | 2022 |
| A preclinical model of THC edibles that produces high-dose cannabimimetic responses A English, F Uittenbogaard, A Torrens, D Sarroza, AVE Slaven, D Piomelli, ... Elife 12, RP89867, 2024 | 1 | 2024 |
| Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for Cannabis and Cannabinoid Research A Torrens Cannabis and Cannabinoid Research 8 (4), 579-579, 2023 | | 2023 |
| Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of Parkinson’s disease F Palese, S Pontis, N Realini, A Torrens, F Ahmed, F Assogna, ... bioRxiv, 2022.02. 10.479850, 2022 | | 2022 |
| Safety and Pharmacokinetics of Varying Doses of Cannabidiol (CBD) and CBD/Tetrahydrocannabinol (THC) Combination Oral Tablet Formulation in Recreational Users: A Randomized … K Smith, N Fogelman, A Torrens, L Sullivan, J Schwartz, D Piiomelli, ... NEUROPSYCHOPHARMACOLOGY 46 (SUPPL 1), 504-505, 2021 | | 2021 |
